Part D – Page 22 – MedPAC

An official website of the United States Government —

Here’s how you know

MedPAC > Our Work > Part D

Part D

Showing 211 - 220 out of 349

Apr 03, 2015 / Transcripts

April 2015 Meeting Transcript

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Apr 03, 2015 / Presentations

Sharing risk in Medicare Part D

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Private Plans

Apr 03, 2015 / Presentations

Polypharmacy and Medicare beneficiaries with a focus on opioid use in Part D

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Physicians And Other Health Professionals

Mar 13, 2015 / Press Releases

MedPAC releases March 2015 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 13, 2015 / Reports

March 2015 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 10, 2015 / Fact Sheets

Fact sheet on MedPAC’s March 2015 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 06, 2015 / Presentations

Sharing risk in Medicare Part D

Research Areas:

Drugs, Devices, and Tests, Private Plans

Mar 01, 2015 / Chapters

Chapter 14: Status report on Part D (March 2015 report)

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Quality